BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., provided a commercialization update for its recently acquired subsidiary, VerdaGenix LLC d/b/a Ancient Extracts USA, highlighting encouraging early operating results. Preliminary May 2026 revenue reached approximately $22,344, representing a 76% month-over-month increase from April's $12,670. The company noted that operations under UNLOCKD ownership only commenced in mid-May following the acquisition closing, meaning the reported revenue reflects a partial month.
Additionally, on June 2, 2026, Ancient Extracts received a purchase order representing approximately $58,823 in retail product value, with an order total of about $29,411 under wholesale pricing terms. All financial figures are preliminary, unaudited, and subject to adjustment.
"We remain in the early stages of integrating Ancient Extracts into the UNLOCKD organization, but we are encouraged by the commercial momentum we are seeing," stated John P. Gorst, Chief Executive Officer of UNLOCKD. "The combination of accelerating revenue, customer demand, and expanding distribution opportunities reinforces our belief that Ancient Extracts possesses many of the qualities that originally attracted us to this acquisition."
Ancient Extracts USA offers a portfolio of functional mushroom products, ceremonial teas, cacao blends, matcha products, shilajit, and wellness-focused consumer goods under the brand philosophy of "Ancient Remedies for Modern Life." The company believes the brand is well-positioned to benefit from growing consumer interest in functional mushrooms, adaptogens, and botanical wellness products.
Dr. Jordan P. Balencic, Chairman and Chief Science Officer of UNLOCKD, commented: "When we evaluated Ancient Extracts, we believed the business possessed a number of attractive characteristics, including a differentiated product portfolio, a loyal customer base, a capital-efficient operating model, and multiple pathways for future growth. While it remains early in the integration process, the initial operating results and commercial traction we are seeing continue to reinforce our conviction in the opportunity."
In a separate update, UNLOCKD Technologies division has begun preliminary planning for future consumer health technology opportunities, including early-stage evaluation of point-of-care testing concepts. These initiatives remain in conceptual stages, and the company expects to pursue dedicated financing for such projects.
For more information, visit www.unlockdinc.com or follow @BFCHco on X. The original release is available at www.newmediawire.com.
